Karen Knudsen, Chief Executive Officer and Executive Director of Parker Institute for Cancer Immunotherapy, shared on LinkedIn:
“Thank you Fierce Pharma!
I am honored to be included in the Fierce 50, alongside such an exceptional group of leaders working to improve health and advance care across the globe. I am especially proud to accept this recognition on behalf of the extraordinary team at Parker Institute, where our focus is to develop and increase access to breakthrough cancer therapies.
Congratulations to my fellow honorees, and thank you for the work you do every day to improve lives!
You can also read: Karen Knudsen’s Exclusive Commentary on the New Moderna Cancer Vaccine
